Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00739362 · ClinicalTrials.gov registry record · Phase 2

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

A Phase 2 study of Obesity and Weight Loss, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Recruiting
Registry status
Phase 2
Development phase
148
Enrollment target
1
Study location

NCT00739362: Recruiting Phase 2 study of Obesity and Weight Loss, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

NCT00739362 is a Phase 2 study of Obesity and Weight Loss that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 148 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00739362, a Phase 2 study of Obesity and Weight Loss, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

RECRUITING
Registry status
Phase 2
Development phase
148 participants
Enrollment target
1
Study location

Study Summary

This study will determine whether electrical stimulation of an area of the brain called the dorsolateral prefrontal cortex, which is important in determining the feeling of fullness after eating, affects how much food a person eats and weight loss over 4 weeks. It will also compare weight changes in people who attend weight loss counseling sessions and those who do not over this period of time. Obese, non-diabetic people between 18 and 60 years of age who are in good health and who live in the Phoenix, AZ, metropolitan area are eligible for this study. Candidates must have a body mass index of 35 kg/m(2) or more and weigh less than 350 pounds. Participants are admitted to the NIH inpatient unit in Phoenix for the first 9 days of the study for tests, which include meal tests to determine eating behaviors and caloric intake, blood and urine tests, glucose tolerance test, weight measurement, psychological assessments and DEXA scan to measure body fat. For 3 of the days, they will be asked to eat all of their food from automated vending machines. Some subjects receive transcranial direct current stimulation (TDCS). For this procedure, electrodes that conduct electricity are placed on the head and arm and the current is turned on for 40 minutes. Some tingling may be felt under the electrodes. Other subjects receive sham TDCS, with the current turned on only very briefly. After the evaluations, subjects are discharged home from the NIH unit and instructed to eat 25 percent fewer calories than they consumed while on a weight maintenance diet the first 3 days of their inpatient stay. They maintain the lower calorie diet at home for 4 weeks. During this period they come to the NIH unit 3 days a week to receive either real or sham TDCS. ...

Primary Outcome

Weight (kg)

Interventions

  • DEVICE Transcranial Direct Current Stimulation (TDCS)
  • OTHER Sham/no-stimulation

Study Locations (1)

Arizona

  • NIDDK, Phoenix - Phoenix

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2009-01-19
Est. Completion 2026-07-31
Phase Phase 2

What NCT00739362 shows while recruiting

NCT00739362 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Direct Current Stimulation (TDCS) is the first listed.

NCT00739362 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT00739362 about?

NCT00739362 is a clinical study titled "Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment". This study will determine whether electrical stimulation of an area of the brain called the dorsolateral prefrontal cortex, which is important in determining the feeling of fullness after eating, affects how much food a person eats and weight loss over 4 weeks. It will also compare weight changes in...

What is the current status of trial NCT00739362?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 148 participants. The study started on 2009-01-19. Estimated completion is 2026-07-31.

What conditions does trial NCT00739362 study?

This clinical trial studies the following conditions: Obesity, Weight Loss, Eating, Electric Stimulation Therapy.

What interventions are being tested in trial NCT00739362?

The interventions under investigation include: Transcranial Direct Current Stimulation (TDCS) (DEVICE), Sham/no-stimulation (OTHER).

Who is sponsoring clinical trial NCT00739362?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00739362 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00739362's enrollment target sits among peer trials

148 389th of 1053 higher than 664 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT03858231 · 148 participants · Phase 4

    Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

  • NCT04639297 · 148 participants · NA

    NeuroVision vs Standard Neuromonitoring

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00739362, the US trial registry maintained by the National Library of Medicine. NCT00739362 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.